Stephen Ranere is a partner in Latham’s Boston office and a member of the firm’s Emerging Companies & Growth Practice. He represents technology and life sciences companies from startup through IPO and beyond.

Mr. Ranere advises companies in the areas of:

  • Mergers and acquisitions
  • Early-stage formation and strategy
  • Venture capital and growth equity financings
  • Public offerings of securities
  • Public company representation
  • Corporate governance matters

Mr. Ranere’s recent representative transactions include advising:

Life Sciences and Digital Health

  • Affini-T Therapeutics on its US$175 million equity financing
  • Overjet on its US$53 million Series C financing and numerous other debt and equity financings
  • PathAI on its US$165 million Series C financing
  • BlueWhale Bio on its US$18 million seed financing 
  • Rapid Micro Biosystems on its IPO and multiple private financings and strategic transactions
  • Neurogene on its US$115 million equity financing and numerous other private financings
  • Kiniksa Pharmaceuticals on its US$150 million IPO and multiple private financings and strategic transactions
  • CloudHealth on its sale to VMware, Inc.
  • Owkin on its US$180 million investment from Sanofi, US$80 million investment from BMS, and other equity financings


  • MadHive on its US$300 million investment from Goldman Sachs Asset Management
  • Merlin Labs on its US$105 million Series B financing
  • OfferFit on its numerous debt and equity financings 
  • Robin on its US$30 million Series C financing
  • Riversand Technologies on its sale to Syndigo
  • Evolv Technology on its US$1.7 billion SPAC merger with NewHold Investment Corporation
  • Actifio on its sale to Google and numerous debt and equity financings
  • Charles River Systems on its US$2.6 billion sale to State Street Corporation
  • Amphenol on its US$400 million acquisition of SSI Controls Technologies
  • Veracode on its US$614 million sale to CA Technologies
  • in its IPO and numerous acquisitions
  • Zipcar on its IPO and sale to Avis Budget Group




Bar Qualification

  • Massachusetts


  • JD, Suffolk University Law School, 2008
    summa cum laude
  • BA, Harvard University, 2000